Get started
UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)

UNITY BIOTECHNOLOGY INC COM USD0.0001 (POST REV SPLIT)

No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Forecast Seasonals

0YC0 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

0YC0 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company